Audit of Global Fund Grants in Mozambique
11 March 2022
Mozambique has made significant progress in fighting HIV, tuberculosis (TB) and malaria. Malaria deaths fell by 70% between 2015 and 2019, TB coverage increased by 46% between 2015 and 2020, and antiretroviral enrolment increased from 42% in 2015 to 68% in 2020. However, improvement is needed in a number of areas, such as low antiretroviral retention, weak monitoring of patients who are lost to follow-up, low viral load coverage and suppression, and programs for key and vulnerable populations.
The supply chain is fragmented and managed by several stakeholders, with diluted accountability and ownership. There are a lack of basic controls related to inventory management, warehousing, and logistics data accuracy, and stock-outs and expiries are impacting services to patients.
Mozambique had utilized less than 35% of its available COVID-19 2020 funding by the end of the grant (June 2021). The low absorption and use of COVID-19 funding could hamper future preparedness as well as programmatic progress.
- Message from the Executive Director: Global Fund Grants in Mozambique
- Global Fund Grants in Mozambique (GF-OIG-22-006 - 11 March 2022)
download in English | Français | Português